In a retrospective review of patients treated with either oral or transdermal rivastigmine, which group required more additional doses of sedation to control antimuscarinic induced delirium?
The group receiving transdermal rivastigmine required more doses of additional sedation compared to oral. Patients receiving the transdermal patch were administered a dose of 9.2 mg/hr and those receiving oral rivastigmine got 6 mg.
Chiew AL, Holford AG, Chan BS, Isoardi KZ. Rivastigmine for the management of anticholinergic delirium. Clinical Toxicology. 2024 Feb 1;62(2):82-7.
Posted in Question Of The Day